{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:35:49Z","timestamp":1793730949803,"version":"4.6.1"},"reference-count":85,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ECCOJC"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1093\/ecco-jcc\/jjw092","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T03:37:05Z","timestamp":1464838625000},"page":"1437-1444","source":"Crossref","is-referenced-by-count":281,"title":["An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab"],"prefix":"10.1093","volume":"10","author":[{"given":"Tim","family":"Wyant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Fedyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brihad","family":"Abhyankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,6,1]]},"reference":[{"key":"2016111703302788000_10.12.1437.1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1601-0825.2011.01811.x","article-title":"Inflammatory bowel disease","volume":"18","author":"Boirivant","year":"2012","journal-title":"Oral Dis"},{"key":"2016111703302788000_10.12.1437.2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.390"},{"key":"2016111703302788000_10.12.1437.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2013.04.001"},{"key":"2016111703302788000_10.12.1437.4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.MIB.0000195385.19268.68","article-title":"Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities","volume":"12","author":"Hanauer","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"2016111703302788000_10.12.1437.5","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i1.6"},{"key":"2016111703302788000_10.12.1437.6","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X10373176"},{"key":"2016111703302788000_10.12.1437.7","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X14558193"},{"key":"2016111703302788000_10.12.1437.8","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2013.73"},{"key":"2016111703302788000_10.12.1437.9","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.043372"},{"key":"2016111703302788000_10.12.1437.10","doi-asserted-by":"publisher","DOI":"10.2217\/imt.12.85"},{"key":"2016111703302788000_10.12.1437.11","doi-asserted-by":"publisher","DOI":"10.1038\/nri3661"},{"key":"2016111703302788000_10.12.1437.12","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X13479826"},{"key":"2016111703302788000_10.12.1437.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04599.x"},{"key":"2016111703302788000_10.12.1437.14","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000218"},{"key":"2016111703302788000_10.12.1437.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2015.07.005"},{"key":"2016111703302788000_10.12.1437.16","first-page":"CD011661","article-title":"Etrolizumab for induction of remission in ulcerative colitis","volume":"12","author":"Rosenfeld","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2016111703302788000_10.12.1437.17","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jju027.021"},{"key":"2016111703302788000_10.12.1437.18","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1752"},{"key":"2016111703302788000_10.12.1437.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2007.05.001"},{"key":"2016111703302788000_10.12.1437.20","unstructured":"FDA. Information on natalizumab. [Marketed as Tysabri.] 2015. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm107198.htm Accessed February 18 2015."},{"key":"2016111703302788000_10.12.1437.21","unstructured":"FDA. FDA approves entyvio to treat ulcerative colitis and Crohn\u2019s disease. 2014. http:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm398065.htm Accessed September 1, 2015."},{"key":"2016111703302788000_10.12.1437.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.06.007"},{"key":"2016111703302788000_10.12.1437.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042982"},{"key":"2016111703302788000_10.12.1437.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215734"},{"key":"2016111703302788000_10.12.1437.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215739"},{"key":"2016111703302788000_10.12.1437.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2005.07.004"},{"key":"2016111703302788000_10.12.1437.27","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2029"},{"key":"2016111703302788000_10.12.1437.28","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2007-8-5-215"},{"key":"2016111703302788000_10.12.1437.29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4049\/jimmunol.151.2.717","article-title":"Selective expression of integrin \u03b14\u03b27 on a subset of human CD4+ memory T cells with hallmarks of gut-trophism","volume":"151","author":"Schweighoffer","year":"1993","journal-title":"J Immunol"},{"key":"2016111703302788000_10.12.1437.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe020157"},{"key":"2016111703302788000_10.12.1437.31","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.4049\/jimmunol.152.7.3282","article-title":"Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo","volume":"152","author":"Hamann","year":"1994","journal-title":"J Immunol"},{"key":"2016111703302788000_10.12.1437.32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902407"},{"key":"2016111703302788000_10.12.1437.33","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.153973"},{"key":"2016111703302788000_10.12.1437.34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4049\/jimmunol.153.2.517","article-title":"Expression and function of the MAdCAM-1 receptor, integrin \u03b14\u03b27, on human leukocytes","volume":"153","author":"Erle","year":"1994","journal-title":"J Immunol"},{"key":"2016111703302788000_10.12.1437.35","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.4049\/jimmunol.156.10.3727","article-title":"A fundamental subdivision of circulating lymphocytes defined by adhesion to mucosal addressin cell adhesion molecule-1. Comparison with vascular cell adhesion molecule-1 and correlation with \u03b27 integrins and memory differentiation","volume":"156","author":"Rott","year":"1996","journal-title":"J Immunol"},{"key":"2016111703302788000_10.12.1437.36","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22940"},{"key":"2016111703302788000_10.12.1437.37","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.26392"},{"key":"2016111703302788000_10.12.1437.38","doi-asserted-by":"publisher","DOI":"10.2174\/156652409789105525"},{"key":"2016111703302788000_10.12.1437.39","doi-asserted-by":"publisher","DOI":"10.1136\/mp.52.4.203"},{"key":"2016111703302788000_10.12.1437.40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803418"},{"key":"2016111703302788000_10.12.1437.41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044397"},{"key":"2016111703302788000_10.12.1437.42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043335"},{"key":"2016111703302788000_10.12.1437.43","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.058404"},{"key":"2016111703302788000_10.12.1437.44","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.080708.082655"},{"key":"2016111703302788000_10.12.1437.45","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70040-5"},{"key":"2016111703302788000_10.12.1437.46","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v111.pm8898653"},{"key":"2016111703302788000_10.12.1437.47","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21896"},{"key":"2016111703302788000_10.12.1437.48","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201110023"},{"key":"2016111703302788000_10.12.1437.49","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202490"},{"key":"2016111703302788000_10.12.1437.50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107829"},{"key":"2016111703302788000_10.12.1437.51","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1999.00855.x"},{"key":"2016111703302788000_10.12.1437.52","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.10.3.7509610"},{"key":"2016111703302788000_10.12.1437.53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2010.03352.x"},{"key":"2016111703302788000_10.12.1437.54","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202x.2001.01481.x"},{"key":"2016111703302788000_10.12.1437.55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2007.03385.x"},{"key":"2016111703302788000_10.12.1437.56","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2682"},{"key":"2016111703302788000_10.12.1437.57","doi-asserted-by":"crossref","unstructured":"Schwarzbauer JE DeSimone DW . Fibronectins, their fibrillogenesis, and in vivo functions. Cold Spring Harb Perspect Biol 2011, July 1;3. doi: 10.1101\/cshperspect.a005041.","DOI":"10.1101\/cshperspect.a005041"},{"key":"2016111703302788000_10.12.1437.58","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13243"},{"key":"2016111703302788000_10.12.1437.59","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307127"},{"key":"2016111703302788000_10.12.1437.60","first-page":"189","article-title":"Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL\/J mouse","volume":"145","author":"Steffen","year":"1994","journal-title":"Am J Pathol"},{"key":"2016111703302788000_10.12.1437.61","doi-asserted-by":"publisher","DOI":"10.1172\/JCI41911"},{"key":"2016111703302788000_10.12.1437.62","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.090437"},{"key":"2016111703302788000_10.12.1437.63","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.65.12.noc80051"},{"key":"2016111703302788000_10.12.1437.64","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.10.1383"},{"key":"2016111703302788000_10.12.1437.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2013.08.011"},{"key":"2016111703302788000_10.12.1437.66","doi-asserted-by":"crossref","unstructured":"D\u2019Haens G Vermeire S Cataldi F . Anti-MAdCAM monoclonal antibody PF-00547659 does not affect immune surveillance in the central nervous system of anti-TNF and immunosuppressant experienced Crohn\u2019s disease patients who are anti-TNF inadequate responders: Results from the TOSCA study. J Crohns Colitis 2014;Suppl 1:S4\u20135.","DOI":"10.1016\/S1873-9946(14)60008-8"},{"key":"2016111703302788000_10.12.1437.67","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e318281f538"},{"key":"2016111703302788000_10.12.1437.68","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.05.008"},{"key":"2016111703302788000_10.12.1437.69","unstructured":"Biogen. Us-Tysabri-update. June 2015 edn. Weston, USA: MedInfo: Biogen, 2015."},{"key":"2016111703302788000_10.12.1437.70","doi-asserted-by":"crossref","unstructured":"Sands B Cohen R Isaacs K . Infusion-related reactions with vedolizumab treatment in patients with UC or CD during the GEMINI 1 AND GEMINI 2 clinical trials. J Crohns Colitis 2015;Suppl 1:S392\u20133.","DOI":"10.1016\/S0016-5085(15)30763-0"},{"key":"2016111703302788000_10.12.1437.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2007.10.001"},{"key":"2016111703302788000_10.12.1437.72","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.28702"},{"key":"2016111703302788000_10.12.1437.73","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.2.206"},{"key":"2016111703302788000_10.12.1437.74","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.105379"},{"key":"2016111703302788000_10.12.1437.75","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00382-2"},{"key":"2016111703302788000_10.12.1437.76","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.28674"},{"key":"2016111703302788000_10.12.1437.77","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/jlb.65.3.349","article-title":"Expression of mucosal addressin cell adhesion molecule-1 [MAdCAM-1] in acute and chronic inflammation","volume":"65","author":"Connor","year":"1999","journal-title":"J Leukoc Biol"},{"key":"2016111703302788000_10.12.1437.78","doi-asserted-by":"crossref","first-page":"G734","DOI":"10.1152\/ajpgi.2000.278.5.G734","article-title":"Cytokine and endothelial cell adhesion molecule expression in interleukin-10-deficient mice","volume":"278","author":"Kawachi","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2016111703302788000_10.12.1437.79","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000160807.53858.1c"},{"key":"2016111703302788000_10.12.1437.80","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.2002.01365.x"},{"key":"2016111703302788000_10.12.1437.81","first-page":"97","article-title":"Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue","volume":"151","author":"Briskin","year":"1997","journal-title":"Am J Pathol"},{"key":"2016111703302788000_10.12.1437.82","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e31828100a4"},{"key":"2016111703302788000_10.12.1437.83","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21236"},{"key":"2016111703302788000_10.12.1437.84","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.03.024"},{"key":"2016111703302788000_10.12.1437.85","doi-asserted-by":"crossref","unstructured":"Colombel JF Sands BE Rutgeerts P . The safety of vedolizumab for ulcerative colitis and Crohn\u2019s disease. Gut 2016. doi: 10.1136\/gutjnl-2015-311079. [Epub ahead of print.]","DOI":"10.1136\/gutjnl-2015-311079"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/10\/12\/1437\/8499439\/jjw092.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T18:29:50Z","timestamp":1692383390000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1093\/ecco-jcc\/jjw092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,1]]},"references-count":85,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,11,17]]},"published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1093\/ecco-jcc\/jjw092"],"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw092","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,1]]}}}